Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 1/2022

10.08.2021 | Original Paper

Clinical insights into a tertiary care center cohort of patients with bicuspid aortic valve

verfasst von: Alexis Théron, Anissa Touil, Noémie Résseguier, Gwenaelle Collod-Beroud, Giulia Norscini, Anne-Sophie Simoni, Gaëlle Odelin, Gilbert Habib, Frédéric Collart, Stéphane Zaffran, Jean-François Avierinos

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Although bicuspid aortic valve (BAV) is one of the most common congenital heart diseases, clinical data associated with valve dysfunction are still limited. We evaluated clinical characteristics and echocardiography of French patients with BAV associated with leaking and stenosis degeneration. We initiated a prospective registry from 2014 to 2018 at a tertiary center. A total of 223 patients (168 males [75%], age 53 ± 17 years) were enrolled. Among these patients 83% had left–right coronary cusps fusion, 80% Sievers type 1 BAV and 49% showed aortic dilatation. Twenty-four patients (11%) had normal valve function, 66 patients (31%) had aortic stenosis (AS), 91 patients (41%) had aortic regurgitation (AR) and 40 patients (17%) had AR and AS. BAV phenotype did not predict neither AS nor AR (all p > 0.1). By multivariable analysis, age > 50 (41.6[10.3–248.2], p < 0.001) and presence of raphe/fusion (12.8[2.4–87.4], p < 0.001) were significantly associated with AS, whereas male gender was associated with AR (5[1.6–16.4], p = 0.005). In addition, leaking degeneration was observed at a much younger age than stenosis (44 ± 14 years vs. 66 ± 10 years, p < 0.01) and among patients with valve dysfunction younger age was independently associated with AR (1.9[1.85–1.94], p < 0.001). In this study we confirmed high prevalence of valve dysfunction at first diagnosis of BAV in a referred population. The degenerative process differs according to type of dysfunction and is mainly dependent on age and gender.
Literatur
1.
Zurück zum Zitat Sievers H-H, Schmidtke C (2007) A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 133:1226–1233CrossRef Sievers H-H, Schmidtke C (2007) A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 133:1226–1233CrossRef
2.
Zurück zum Zitat Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D (2005) Mutations in NOTCH1 cause aortic valve disease. Nature 437:270–274CrossRef Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D (2005) Mutations in NOTCH1 cause aortic valve disease. Nature 437:270–274CrossRef
3.
Zurück zum Zitat Michelena HI, Suri RM, Katan O, Eleid MF, Clavel M, Maurer MJ, Pellikka PA, Mahoney D, Enriquez-Sarano M (2016) Sex differences and survival in adults with bicuspid aortic valves: verification in 3 contemporary echocardiographic cohorts. J Am Heart Assoc 5:e004211CrossRef Michelena HI, Suri RM, Katan O, Eleid MF, Clavel M, Maurer MJ, Pellikka PA, Mahoney D, Enriquez-Sarano M (2016) Sex differences and survival in adults with bicuspid aortic valves: verification in 3 contemporary echocardiographic cohorts. J Am Heart Assoc 5:e004211CrossRef
4.
Zurück zum Zitat Hoffman JIE, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900CrossRef Hoffman JIE, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900CrossRef
5.
Zurück zum Zitat Larson EW, Edwards WD (1984) Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 53:849–855CrossRef Larson EW, Edwards WD (1984) Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 53:849–855CrossRef
6.
Zurück zum Zitat Michelena HI, Prakash SK, Della Corte A, Bissell MM, Anavekar N, Mathieu P, Bossé Y, Limongelli G, Bossone E, Benson DW, Lancellotti P, Isselbacher EM, Enriquez-Sarano M, Sundt TM, Pibarot P, Evangelista A, Milewicz DM, Body SC, BAVCon Investigators (2014) Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation 129:2691–2704CrossRef Michelena HI, Prakash SK, Della Corte A, Bissell MM, Anavekar N, Mathieu P, Bossé Y, Limongelli G, Bossone E, Benson DW, Lancellotti P, Isselbacher EM, Enriquez-Sarano M, Sundt TM, Pibarot P, Evangelista A, Milewicz DM, Body SC, BAVCon Investigators (2014) Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation 129:2691–2704CrossRef
7.
Zurück zum Zitat Michelena HI, Desjardins VA, Avierinos J-F, Russo A, Nkomo VT, Sundt TM, Pellikka PA, Tajik AJ, Enriquez-Sarano M (2008) Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 117:2776–2784CrossRef Michelena HI, Desjardins VA, Avierinos J-F, Russo A, Nkomo VT, Sundt TM, Pellikka PA, Tajik AJ, Enriquez-Sarano M (2008) Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 117:2776–2784CrossRef
8.
Zurück zum Zitat Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, Eidem B, Edwards WD, Sundt TM, Enriquez-Sarano M (2011) Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 306:1104–1112CrossRef Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, Eidem B, Edwards WD, Sundt TM, Enriquez-Sarano M (2011) Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 306:1104–1112CrossRef
9.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, ESC Scientific Document Group (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, ESC Scientific Document Group (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef
10.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM, Thompson A (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 70:252–289CrossRef Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM, Thompson A (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 70:252–289CrossRef
11.
Zurück zum Zitat Atkins SK, Sucosky P (2014) Etiology of bicuspid aortic valve disease: focus on hemodynamics. World J Cardiol 6:1227–1233CrossRef Atkins SK, Sucosky P (2014) Etiology of bicuspid aortic valve disease: focus on hemodynamics. World J Cardiol 6:1227–1233CrossRef
12.
Zurück zum Zitat Sun L, Chandra S, Sucosky P (2012) Ex vivo evidence for the contribution of hemodynamic shear stress abnormalities to the early pathogenesis of calcific bicuspid aortic valve disease. PLoS ONE 7:e48843CrossRef Sun L, Chandra S, Sucosky P (2012) Ex vivo evidence for the contribution of hemodynamic shear stress abnormalities to the early pathogenesis of calcific bicuspid aortic valve disease. PLoS ONE 7:e48843CrossRef
13.
Zurück zum Zitat Firth D (1993) Bias reduction of maximum likelihood. Biometrika 80:27–38CrossRef Firth D (1993) Bias reduction of maximum likelihood. Biometrika 80:27–38CrossRef
14.
Zurück zum Zitat Michelena HI, Mankad SV (2017) Sex differences in bicuspid aortic valve adults: who deserves our attention, men or women? Circ Cardiovasc Imaging 10:e006123CrossRef Michelena HI, Mankad SV (2017) Sex differences in bicuspid aortic valve adults: who deserves our attention, men or women? Circ Cardiovasc Imaging 10:e006123CrossRef
15.
Zurück zum Zitat Roberts WC, Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111:920–925CrossRef Roberts WC, Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111:920–925CrossRef
16.
Zurück zum Zitat Kang J-W, Song HG, Yang DH, Baek S, Kim D-H, Song J-M, Kang D-H, Lim T-H, Song J-K (2013) Association between bicuspid aortic valve phenotype and patterns of valvular dysfunction and bicuspid aortopathy. JACC Cardiovasc Imaging 6:150–161CrossRef Kang J-W, Song HG, Yang DH, Baek S, Kim D-H, Song J-M, Kang D-H, Lim T-H, Song J-K (2013) Association between bicuspid aortic valve phenotype and patterns of valvular dysfunction and bicuspid aortopathy. JACC Cardiovasc Imaging 6:150–161CrossRef
17.
Zurück zum Zitat Kong WKF, Delgado V, Poh KK, Regeer MV, Ng ACT, McCormack L, Yeo TC, Shanks M, Parent S, Enache R, Popescu BA, Liang M, Yip JW, Ma LCW, Kamperidis V, Van Rosendael PJ, Van Der Velde ET, Ajmone Marsan N, Bax JJ (2017) Prognostic implications of raphe in bicuspid aortic valve anatomy. JAMA Cardiol 2:285–292CrossRef Kong WKF, Delgado V, Poh KK, Regeer MV, Ng ACT, McCormack L, Yeo TC, Shanks M, Parent S, Enache R, Popescu BA, Liang M, Yip JW, Ma LCW, Kamperidis V, Van Rosendael PJ, Van Der Velde ET, Ajmone Marsan N, Bax JJ (2017) Prognostic implications of raphe in bicuspid aortic valve anatomy. JAMA Cardiol 2:285–292CrossRef
18.
Zurück zum Zitat Bäck M, Gasser TC, Michel J-B, Caligiuri G (2013) Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovasc Res 99:232–241CrossRef Bäck M, Gasser TC, Michel J-B, Caligiuri G (2013) Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovasc Res 99:232–241CrossRef
19.
Zurück zum Zitat Robicsek F, Thubrikar MJ, Cook JW, Fowler B (2004) The congenitally bicuspid aortic valve: how does it function? Why does it fail? Ann Thorac Surg 77:177–185CrossRef Robicsek F, Thubrikar MJ, Cook JW, Fowler B (2004) The congenitally bicuspid aortic valve: how does it function? Why does it fail? Ann Thorac Surg 77:177–185CrossRef
20.
Zurück zum Zitat Marom G, Kim H-S, Rosenfeld M, Raanani E, Haj-Ali R (2013) Fully coupled fluid-structure interaction model of congenital bicuspid aortic valves: effect of asymmetry on hemodynamics. Med Biol Eng Comput 51:839–848CrossRef Marom G, Kim H-S, Rosenfeld M, Raanani E, Haj-Ali R (2013) Fully coupled fluid-structure interaction model of congenital bicuspid aortic valves: effect of asymmetry on hemodynamics. Med Biol Eng Comput 51:839–848CrossRef
21.
Zurück zum Zitat Yang L-T, Enriquez-Sarano M, Michelena HI (2020) The bicuspid aortic valve raphe: an evolving structure. Eur Hear J Cardiovasc Imaging 21:590–590CrossRef Yang L-T, Enriquez-Sarano M, Michelena HI (2020) The bicuspid aortic valve raphe: an evolving structure. Eur Hear J Cardiovasc Imaging 21:590–590CrossRef
22.
Zurück zum Zitat Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89(12):1147–1154CrossRef Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89(12):1147–1154CrossRef
Metadaten
Titel
Clinical insights into a tertiary care center cohort of patients with bicuspid aortic valve
verfasst von
Alexis Théron
Anissa Touil
Noémie Résseguier
Gwenaelle Collod-Beroud
Giulia Norscini
Anne-Sophie Simoni
Gaëlle Odelin
Gilbert Habib
Frédéric Collart
Stéphane Zaffran
Jean-François Avierinos
Publikationsdatum
10.08.2021
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 1/2022
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-021-02366-1

Weitere Artikel der Ausgabe 1/2022

The International Journal of Cardiovascular Imaging 1/2022 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.